RGICX | VTISX | RGICX / VTISX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 8 years | - |
Gain YTD | 5.674 | 6.094 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.1B | 443B | 3% |
Annual Yield % from dividends | 2.05 | 3.32 | 62% |
Returns for 1 year | 7.95 | 8.85 | 90% |
Returns for 3 years | -2.36 | 1.14 | -207% |
Returns for 5 years | 9.82 | 14.05 | 70% |
Returns for 10 years | 23.93 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPIB | 33.03 | -0.02 | -0.06% |
SPDR® Portfolio Interm Term Corp Bd ETF | |||
FMAR | 43.58 | -0.05 | -0.11% |
FT Vest US Equity Buffer ETF Mar | |||
GNOM | 10.29 | -0.04 | -0.40% |
Global X Genomics & Biotechnology ETF | |||
RTH | 233.18 | -2.24 | -0.95% |
VanEck Retail ETF | |||
TPOR | 32.01 | -0.50 | -1.54% |
Direxion Dly Transp Bull 3X Shrs ETF |